Abnormal immune function in vivo in a murine model of lysosomal storage disease

被引:28
作者
Daly, TM
Lorenz, RG
Sands, MS
机构
[1] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Lab Med, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
关键词
D O I
10.1203/00006450-200006000-00012
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Lysosomal storage diseases are a class of inborn errors of metabolism that lead to widespread disease in multiple tissues. The murine model of mucopolysaccharidosis type VII (MPS VII) closely parallels the human syndrome and has been extensively used to investigate the natural history and therapeutic strategies for lysosomal storage diseases in general. Here we demonstrate a previously undescribed immune defect in the MPS VII mouse. Although the normal populations of cells are present in lymph nodes of these mice, MPS VII mice show a blunted T cell proliferative response and decreased antibody production after immunization with antigens. One mechanism of this defect is ineffective processing of protein antigens, as responses to peptide antigens are normal. This phenotype is presumably caused by the lysosomal disorder, as the defect can be corrected in vivo by direct enzyme replacement therapy. These findings have implications for the use of this animal model, and may have clinical significance for other, more-common lysosomal storage diseases.
引用
收藏
页码:757 / 762
页数:6
相关论文
共 34 条
[1]  
ALLEN PM, 1984, J IMMUNOL, V132, P1077
[2]   INHIBITION OF LEUKOCYTIC LYSOSOMAL ENZYMES BY GLYCOSAMINOGLYCANS INVITRO [J].
AVILA, JL ;
CONVIT, J .
BIOCHEMICAL JOURNAL, 1975, 152 (01) :57-64
[3]   BEHAVIORAL CONSEQUENCES OF BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII [J].
BASTEDO, L ;
SANDS, MS ;
LAMBERT, DT ;
PISA, MA ;
BIRKENMEIER, E ;
CHANG, PL .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (03) :1180-1186
[4]   MURINE MUCOPOLYSACCHARIDOSIS TYPE-VII - CHARACTERIZATION OF A MOUSE WITH BETA-GLUCURONIDASE DEFICIENCY [J].
BIRKENMEIER, EH ;
DAVISSON, MT ;
BEAMER, WG ;
GANSCHOW, RE ;
VOGLER, CA ;
GWYNN, B ;
LYFORD, KA ;
MALTAIS, LM ;
WAWRZYNIAK, CJ .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1258-1266
[5]  
BIRKENMEIER EH, 1991, BLOOD, V78, P3081
[6]  
CHEN JS, 1991, J IMMUNOL, V147, P3672
[7]   Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease [J].
Daly, TM ;
Vogler, C ;
Levy, B ;
Haskins, ME ;
Sands, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :2296-2300
[8]   Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged β-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice [J].
Daly, TM ;
Okuyama, T ;
Vogler, C ;
Haskins, ME ;
Muzyczka, N ;
Sands, MS .
HUMAN GENE THERAPY, 1999, 10 (01) :85-94
[9]  
GAMMON G, 1987, IMMUNOL REV, V98, P53
[10]   Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules [J].
Germain, RN ;
Castellino, F ;
Han, RC ;
Sousa, CR ;
Romagnoli, P ;
SadeghNasseri, S ;
Zhong, GM .
IMMUNOLOGICAL REVIEWS, 1996, 151 :5-30